Changmao Biological (00954.HK) announced its interim results with a shareholder net loss of 25.79 million yuan, an increase of 37.28% year-on-year.

Zhongtong Financial APP News, Changmao Biology (00954.HK) announced its mid-term performance in 2025, with revenue of approximately 272 million yuan, a decrease of 13.23% year-on-year; the loss attributable to the company's shareholders was 25.79 million yuan, an increase of 37.28% year-on-year; the loss per share was 0.049 yuan.